| 2026-03-18 |
详情>>
股本变动：
变动后总股本2672.58万股
|
| 2026-03-18 |
详情>>
业绩披露：
2025年年报每股收益-5.68美元,归母净利润-826.1万美元,同比去年增长-88.87%
|
| 2026-03-04 |
股东大会：
将于2026-04-13召开股东大会
会议内容 ▼▲
- 1.To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, pursuant to the Company’s ELOC Purchase Agreement (as defined herein) ;
2.To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, in the form set forth on Appendix A attached to this Proxy Statement, to effect a reverse stock split (the “Reverse Stock Split”) with respect to our issued and outstanding common stock, par value $0.0001 per share, at a ratio ranging between 1-for-10 and 1-for-25, with the ratio at which the Reverse Stock Split would be effected to be a ratio within the range to be determined at the discretion of our Board of Directors and included in a public announcement by the Company before the effectiveness of the Reverse Stock Split ;
3.To approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve Proposals No. 1 and No. 2;
4.To transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2026-01-07 |
股东大会：
将于2026-01-29召开股东大会
会议内容 ▼▲
- 1.To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, pursuant to the Company’s ELOC Purchase Agreement ;
2.To approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve Proposal No. 1;
3.To transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2025-11-18 |
复牌提示：
2025-11-18 09:44:29 停牌，复牌日期 2025-11-18 09:49:29
|
| 2025-11-14 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.58美元,归母净利润-574.1万美元,同比去年增长-122.95%
|
| 2025-09-29 |
股东大会：
将于2025-11-07召开股东大会
会议内容 ▼▲
- 1.To authorize and approve, for purposes of complying with Nasdaq listing rule 5635(d), the ability to issue warrants to purchase shares of the Company’s common stock, and the issuance of common stock underlying such warrants, pursuant to the terms of a warrant inducement transaction set forth in the Inducement Letter, dated September 2, 2025 (Proposal No. 1);
2.To authorize and approve, for purposes of complying with Nasdaq listing rule 5635(d), the ability to issue warrants to purchase shares of the Company’s common stock, and the issuance of common stock underlying such warrants, pursuant to with an offering of securities of the Company that occurred on June 30, 2025 (the “Proposal No. 2”);
3.To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, in the form set forth on Appendix A attached to this Proxy Statement, to effect a reverse stock split (the “Reverse Stock Split”) with respect to our issued and outstanding common stock, par value $0.0001 per share, at a ratio of 1-for-7 to 1-for-12, with the ratio at which the Reverse Stock Split would be effected to be a ratio within the range to be determined at the discretion of our Board of Directors and included in a public announcement by the Company before the effectiveness of the Reverse Stock Split (Proposal No. 3);
4.To approve the adjournment of the Special Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve Proposal No. 1, Proposal No. 2 and/or Proposal No. 3 (Proposal No. 4);
5.To transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.43美元,归母净利润-376.1万美元,同比去年增长-82.22%
|
| 2025-06-26 |
股东大会：
将于2025-08-12召开股东大会
会议内容 ▼▲
- 1.To elect one Class III director to serve on our board of directors for a term of three years or until our 2028 Annual Meeting of Stockholders, for which Tuvia Barlev is the nominee ;
2.To ratify the appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 ;
3.To approve the Actelis 2025 Equity Incentive Plan (the “2025 Plan”) ;
4.To approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve Proposal No. 1, Proposal No. 2 and/or Proposal No. 3 ;
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.22美元,归母净利润-186万美元,同比去年增长6.34%
|
| 2025-05-13 |
财报披露：
美东时间 2025-05-13 盘后发布财报
|
| 2025-03-24 |
详情>>
业绩披露：
2024年年报每股收益-0.85美元,归母净利润-437.4万美元,同比去年增长30.42%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.59美元,归母净利润-257.5万美元,同比去年增长40.87%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.51美元,归母净利润-206.4万美元,同比去年增长40.83%
|
| 2024-06-25 |
股东大会：
将于2024-07-30召开股东大会
会议内容 ▼▲
- 1.To elect one Class II director to serve on our board of directors for a term of three years or until our 2027 Annual Meeting of Stockholders, for which Joseph Moscovitz is the nominee;
2.To ratify the appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To authorize for purposes of complying with NASDAQ listing rule 5635(D) the ability to issue shares of the Company’s common stock upon the exercise of our Common Stock warrants issued pursuant to the terms of a private placement financing transaction set forth in the Securities Purchase Agreement, dated December 17, 2023 (the “Purchase Agreement”)
4.To approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve Proposal No. 1, Proposal No. 2 and/or Proposal No. 3 ;
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.5美元,归母净利润-198.6万美元,同比去年增长-4.8%
|
| 2024-04-01 |
详情>>
内部人交易：
Barlev Tuvia股份增加8965.00股
|
| 2024-03-26 |
详情>>
业绩披露：
2023年年报每股收益-2.61美元,归母净利润-628.6万美元,同比去年增长42.76%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.93美元,归母净利润-435.5万美元,同比去年增长48.76%
|
| 2023-07-05 |
股东大会：
将于2023-08-04召开股东大会
会议内容 ▼▲
- 1.To elect one Class I Director to serve for a term of three years until our 2026 Annual Meeting of Stockholders (“Proposal 1”);
2.To ratify the appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Proposal 2”);
3.To approve the Additional 2023 RSU Grants (as defined below) (“Proposal 3”);
4.To approve the Annual RSU Grants (as defined below) (“Proposal 4”);
5.To approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve Proposal 1, Proposal 2, Proposal 3 and/or Proposal 4 (“Proposal 5”);
6.To conduct any other business as may properly come before the meeting or any adjournment thereof.
|
| 2023-04-19 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|